CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

86 hedge funds and large institutions have $98.5M invested in Cascadian Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$463K
Puts
$201K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$618K
27
$605K
28
$598K
29
$526K
30
$437K
31
$430K
32
$328K
33
$303K
34
$295K
35
$290K
36
$284K
37
$271K
38
$247K
39
$190K
40
$187K
41
$161K
42
$159K
43
$146K
44
$129K
45
$116K
46
$115K
47
$109K
48
$109K
49
$107K
50
$107K